90 related articles for article (PubMed ID: 606739)
1. Accumulation of technetium-99m stannous pyrophosphate in contused myocardium.
Downey J; Chagrasulis R; Fore D; Parmley LF
J Nucl Med; 1977 Dec; 18(12):1171-5. PubMed ID: 606739
[TBL] [Abstract][Full Text] [Related]
2. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
Kowalsky RJ; Dalton DR
Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
[TBL] [Abstract][Full Text] [Related]
3. Myocsrdial uptake of technetium-99m stannous pyrophosphate following direct current transthoracic countershock.
DiCola VC; Freedman GS; Downing SE; Zaret BL
Circulation; 1976 Dec; 54(6):980-6. PubMed ID: 991415
[TBL] [Abstract][Full Text] [Related]
4. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
[TBL] [Abstract][Full Text] [Related]
5. Myocardial uptake of technetium-99m stannous pyrophosphate in experimental viral myopericarditis.
Kadota K; Matsumori A; Kambara H; Kawai C
J Nucl Med; 1979 Oct; 20(10):1047-50. PubMed ID: 231641
[TBL] [Abstract][Full Text] [Related]
6. Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate.
Jansen DE; Corbett JR; Buja LM; Hansen C; Ugolini V; Parkey RW; Willerson JT
Circulation; 1987 Mar; 75(3):611-7. PubMed ID: 3493088
[TBL] [Abstract][Full Text] [Related]
7. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
Huckell VF; Lyster DM; Morrison RT; Cooper JA
Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m stannous pyrophosphate myocardial scintigraphy in the recognition of acute subendocardial myocardial infarction.
Poliner LR; Parkey RW; Buja LM; Stokely EM; Bonte FJ; Willerson JT
Tex Med; 1977 Aug; 73(8):74-81. PubMed ID: 882934
[No Abstract] [Full Text] [Related]
9. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
Zimmer AM
Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m(Sn2+)pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons.
Bianco JA; Kemper AJ; Taylor A; Lazewatsky J; Tow DE; Khuri SF
J Nucl Med; 1983 Jun; 24(6):485-91. PubMed ID: 6854398
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous display of gated technetium-99m stannous pyrophosphate and gated blood-pool scintigrams.
Corbett JR; Lewis SE; Dehmer G; Bonte FJ; Parkey RW; Buja LM; Willerson JT
J Nucl Med; 1981 Aug; 22(8):671-7. PubMed ID: 7264755
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents.
Kelbaek H; Fogh J
J Nucl Med; 1985 Jan; 26(1):68-71. PubMed ID: 3965654
[TBL] [Abstract][Full Text] [Related]
13. [Technetium-99m stannous pyrophosphate myocardial scintigraphy].
Tada A; Bungyo H; Hisada K
Rinsho Hoshasen; 1983 Feb; 28(2):345-6. PubMed ID: 6865056
[No Abstract] [Full Text] [Related]
14. Re: Stability of stannous ion in stannous pyrophosphate kits.
Kowalsky RJ; Chilton HM
J Nucl Med; 1983 Nov; 24(11):1080-1. PubMed ID: 6631529
[No Abstract] [Full Text] [Related]
15. Mechanisms contributing to myocardial accumulation of technetium-99m stannous pyrophosphate after coronary arterial occlusion.
Coleman RE; Klein MS; Ahmed SA; Weiss ES; Buchholz WM; Sobel BE
Am J Cardiol; 1977 Jan; 39(1):55-9. PubMed ID: 188332
[TBL] [Abstract][Full Text] [Related]
16. Perioperative myocardial infarction diagnosed by technetium 99m stannous pyrophosphate myocardial scintigrams.
Platt MR; Mills LJ; Parkey RW; Willerson JT; Bonte FJ; Shapiro W; Sugg WL
Circulation; 1976 Dec; 54(6 Suppl):III24-7. PubMed ID: 991422
[TBL] [Abstract][Full Text] [Related]
17. Myocardial uptake of Tc-99m skeletal agents in the rat after experimental induction of microscopic foci of injury.
Miller DG; Gilmour RF; Grossman ZD; Mallov S; Wistow BW; Rohner RF
J Nucl Med; 1977 Oct; 18(10):1005-9. PubMed ID: 198448
[TBL] [Abstract][Full Text] [Related]
18. Studies on the labeling of streptokinase with 99mTc for use as a radiopharmaceutical in the detection of deep-vein thrombosis: concise communication.
Duffy MJ; Duffy GJ
J Nucl Med; 1977 May; 18(5):483-5. PubMed ID: 16092
[TBL] [Abstract][Full Text] [Related]
19. Acute myocardial infarction: clinical application of technetium 99m stannous pyrophosphate infarct scintigraphy.
Werner JA; Botvinick EH; Shames DM; Parmley WW
West J Med; 1977 Dec; 127(6):464-78. PubMed ID: 339549
[TBL] [Abstract][Full Text] [Related]
20. Effect of methylprednisolone upon technetium-99m pyrophosphate assessment myocardial necrosis in the canine countershock model.
Schneider RM; Hayslett JP; Downing SE; Berger HJ; Donabedian RK; Zaret BL
Circulation; 1977 Dec; 56(6):1029-34. PubMed ID: 923041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
